Michael Yee
Stock Analyst at UBS
(2.20)
# 3,014
Out of 4,361 analysts
1335
Total ratings
43.5%
Success rate
0.4%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORKA Oruka Therapeutics | Rated: Buy | $100 | $55.23 | +81.06% | 6 | Jun 2, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $145 | $115.65 | +25.38% | 5 | Jun 2, 2026 | |
| MRNA Moderna | Maintained: Hold | $45 | $45.64 | -1.40% | 70 | Jun 2, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $60 | $32.76 | +83.15% | 4 | May 31, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $145 → $175 | $151.31 | +15.66% | 4 | May 31, 2026 | |
| PFE Pfizer | Maintained: Hold | $27 | $25.55 | +5.68% | 7 | May 30, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $70 | $54.46 | +28.53% | 2 | May 28, 2026 | |
| BIIB Biogen | Reiterated: Buy | $225 | $188.83 | +19.15% | 170 | May 15, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $60 → $76 | $51.26 | +48.26% | 4 | May 13, 2026 | |
| ALXO ALX Oncology Holdings | Maintained: Buy | $6 | $1.78 | +237.08% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $78.77 | +26.95% | 5 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,250 | $1,064.15 | +17.46% | 6 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $400 | $328.26 | +21.85% | 185 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $127.57 | +37.18% | 187 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.09 | +193.40% | 2 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $80 | $33.22 | +140.86% | 14 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $27.87 | +79.40% | 2 | Mar 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $14.94 | -12.99% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $545 | $425.09 | +28.21% | 124 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $20 | $5.25 | +280.95% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $4.90 | +42.86% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $3.48 | +101.15% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $30.70 | +95.44% | 5 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $22.95 | +96.08% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $230 | $215.40 | +6.78% | 4 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $15.87 | +215.06% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $17.15 | +104.08% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $60 | $44.68 | +34.29% | 15 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $25 | $19.35 | +29.20% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $2.05 | +290.24% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $28.96 | -3.31% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 → $45 | $10.69 | +320.95% | 21 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $29.64 | +85.59% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $3.5 | $4.28 | -18.22% | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $9.19 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $18 | $4.10 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $8 | $2.57 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $14.47 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $48.54 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $1.14 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $15 | $6.84 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $30 | $3.14 | n/a | 30 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $24.49 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $31 | $150,000.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $0.7753 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $6.13 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $8.61 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $3.38 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0002 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $53.32 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $20.89 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.38 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $30.02 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $540.05 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $602.92 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $6.98 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.71 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $92.24 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $86.97 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $47.68 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $222.89 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $73.75 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $293.30 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $213.98 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.0001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $33.08 | n/a | 7 | Apr 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $16.25 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $377.92 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $389.03 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.30 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $4.26 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $70.82 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $4.31 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $244.58 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
Oruka Therapeutics
Jun 2, 2026
Rated: Buy
Price Target: $100
Current: $55.23
Upside: +81.06%
Merck & Co.
Jun 2, 2026
Maintained: Buy
Price Target: $145
Current: $115.65
Upside: +25.38%
Moderna
Jun 2, 2026
Maintained: Hold
Price Target: $45
Current: $45.64
Upside: -1.40%
Cogent Biosciences
May 31, 2026
Maintained: Buy
Price Target: $60
Current: $32.76
Upside: +83.15%
Revolution Medicines
May 31, 2026
Rated: Buy
Price Target: $145 → $175
Current: $151.31
Upside: +15.66%
Pfizer
May 30, 2026
Maintained: Hold
Price Target: $27
Current: $25.55
Upside: +5.68%
Bristol-Myers Squibb Company
May 28, 2026
Maintained: Buy
Price Target: $70
Current: $54.46
Upside: +28.53%
Biogen
May 15, 2026
Reiterated: Buy
Price Target: $225
Current: $188.83
Upside: +19.15%
AnaptysBio
May 13, 2026
Maintained: Buy
Price Target: $60 → $76
Current: $51.26
Upside: +48.26%
ALX Oncology Holdings
May 12, 2026
Maintained: Buy
Price Target: $6
Current: $1.78
Upside: +237.08%
May 11, 2026
Maintained: Buy
Price Target: $100
Current: $78.77
Upside: +26.95%
Apr 20, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,064.15
Upside: +17.46%
Apr 13, 2026
Maintained: Buy
Price Target: $390 → $400
Current: $328.26
Upside: +21.85%
Apr 8, 2026
Reiterated: Buy
Price Target: $175
Current: $127.57
Upside: +37.18%
Apr 1, 2026
Reiterated: Buy
Price Target: $12
Current: $4.09
Upside: +193.40%
Mar 27, 2026
Maintained: Buy
Price Target: $50 → $80
Current: $33.22
Upside: +140.86%
Mar 22, 2026
Maintained: Buy
Price Target: $50
Current: $27.87
Upside: +79.40%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $14.94
Upside: -12.99%
Mar 9, 2026
Maintained: Buy
Price Target: $545
Current: $425.09
Upside: +28.21%
Mar 5, 2026
Maintained: Buy
Price Target: $3 → $20
Current: $5.25
Upside: +280.95%
Mar 3, 2026
Maintained: Hold
Price Target: $10 → $7
Current: $4.90
Upside: +42.86%
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.48
Upside: +101.15%
Feb 24, 2026
Reiterated: Buy
Price Target: $60
Current: $30.70
Upside: +95.44%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $22.95
Upside: +96.08%
Feb 5, 2026
Maintained: Hold
Price Target: $230
Current: $215.40
Upside: +6.78%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $15.87
Upside: +215.06%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $17.15
Upside: +104.08%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $60
Current: $44.68
Upside: +34.29%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $25
Current: $19.35
Upside: +29.20%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.05
Upside: +290.24%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $28.96
Upside: -3.31%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $30 → $45
Current: $10.69
Upside: +320.95%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $29.64
Upside: +85.59%
Jun 25, 2025
Maintained: Hold
Price Target: $1.5 → $3.5
Current: $4.28
Upside: -18.22%
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $9.19
Upside: n/a
Mar 13, 2025
Maintained: Buy
Price Target: $24 → $18
Current: $4.10
Upside: n/a
Mar 6, 2025
Maintained: Buy
Price Target: $145 → $8
Current: $2.57
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $14.47
Upside: n/a
Mar 22, 2023
Maintained: Buy
Price Target: $26
Current: $48.54
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $1.14
Upside: n/a
Aug 10, 2021
Maintained: Hold
Price Target: $45 → $15
Current: $6.84
Upside: n/a
Feb 12, 2021
Downgraded: Hold
Price Target: $40 → $30
Current: $3.14
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $10 → $7
Current: $24.49
Upside: n/a
Dec 21, 2018
Maintained: Buy
Price Target: $40 → $31
Current: $150,000.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $0.7753
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $6.13
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $8.61
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $3.38
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0002
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $53.32
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $20.89
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $3.38
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $30.02
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $540.05
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $602.92
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $6.98
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $2.71
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $92.24
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $86.97
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $47.68
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $133
Current: $222.89
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $73.75
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $293.30
Upside: n/a
Jul 28, 2016
Maintained: Buy
Price Target: $115
Current: $213.98
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.0001
Upside: n/a
Apr 20, 2016
Reiterated: Buy
Price Target: $85 → $75
Current: $33.08
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $16.25
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $377.92
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $389.03
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $3.30
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $4.26
Upside: n/a
Aug 5, 2015
Maintained: Hold
Price Target: $9
Current: $70.82
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $4.31
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $244.58
Upside: n/a
Mar 20, 2012
Maintained: Buy
Price Target: $28
Current: $0.0008
Upside: n/a